| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 工艺研究与开发(元) | 47,223,698.99 | 63,706,140.84 | 28,584,452.29 | 48,160,997.27 | 21,965,693.22 |
| 商业化生产(元) | 61,640,888.54 | 197,906,939.76 | 123,461,379.48 | 165,214,033.62 | 79,196,377.63 |
| 药物发现(元) | 246,397,797.49 | 396,982,662.49 | 185,783,780.72 | 316,571,851.12 | 158,235,327.69 |
| 其他业务(元) | 9,143,921.12 | - | - | - | - |
| 营业成本(元) | |||||
| 工艺研究与开发(元) | 36,749,934.84 | 54,703,274.83 | 26,770,532.76 | 49,153,903.95 | 20,367,456.24 |
| 商业化生产(元) | 64,057,244.40 | 182,492,019.50 | 107,527,911.76 | 152,576,084.03 | 76,451,558.83 |
| 药物发现(元) | 161,361,760.86 | 261,274,819.37 | 119,626,227.22 | 212,801,042.62 | 105,747,505.12 |
| 其他业务(元) | 567,791.21 | - | - | - | - |
| 毛利(元) | |||||
| 工艺研究与开发(元) | 10,473,764.15 | 9,002,866.01 | 1,813,919.53 | -992,906.68 | 1,598,236.98 |
| 商业化生产(元) | -2,416,355.86 | 15,414,920.26 | 15,933,467.72 | 12,637,949.59 | 2,744,818.80 |
| 药物发现(元) | 85,036,036.63 | 135,707,843.12 | 66,157,553.50 | 103,770,808.50 | 52,487,822.57 |
| 其他业务(元) | 8,576,129.91 | - | - | - | - |
| 毛利率(%) | |||||
| 工艺研究与开发(%) | 22.18 | 14.13 | 6.35 | -2.06 | 7.28 |
| 商业化生产(%) | -3.92 | 7.79 | 12.91 | 7.65 | 3.47 |
| 药物发现(%) | 34.51 | 34.18 | 35.61 | 32.78 | 33.17 |
| 其他业务(%) | 93.79 | - | - | - | - |
| 收入构成(%) | |||||
| 工艺研究与开发(%) | 12.96 | 9.67 | 8.46 | 9.09 | 8.47 |
| 商业化生产(%) | 16.92 | 30.05 | 36.55 | 31.18 | 30.53 |
| 药物发现(%) | 67.62 | 60.28 | 54.99 | 59.74 | 61.00 |
| 其他业务(%) | 2.51 | - | - | - | - |
| 毛利构成(%) | |||||
| 工艺研究与开发(%) | 10.30 | 5.62 | 2.16 | -0.86 | 2.81 |
| 商业化生产(%) | -2.38 | 9.63 | 18.99 | 10.95 | 4.83 |
| 药物发现(%) | 83.64 | 84.75 | 78.85 | 89.91 | 92.36 |
| 其他业务(%) | 8.44 | - | - | - | - |